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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
We aim to assess the effects of end-of-life care pathways, compared with usual care or with care guided by another end-of-life care
pathway across all healthcare settings (hospitals, residential aged care facilities, community). In particular, we aim to assess the effects
on symptom severity and quality of life of people who are dying and/or those related to the care such as families, caregivers and health
professionals.
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B A C K G R O U N D
Description of the condition
Populations of developed countries are ageing (United Nations
2002). As populations age, the pattern of diseases they die from
also changes (WHO 2004). With advanced ageing, there is an
increased risk of death from chronic diseases such as cancer and
heart failure (WHO 2001). For example, cancer was estimated
to account for about 7 million deaths (12% of all deaths) world-
wide in 2000 (WHO 2001). As a result, palliative care has been
identified as one of the worldwide public health priorities (WHO
2004). Whilst palliative care is concerned with “the quality of life
of patients and families who face life-threatening illness, by pro-
viding pain and symptom relief, spiritual and psychosocial support
from diagnosis to the end of life and bereavement.” (WHO2009),
end-of-life care focuses on the last days and hours of life (Lunney
2003). The need to provide high quality end-of-life care is essen-
tial. The needs of dying people may include, but are not limited
to, knowing when death is coming, understanding what can be ex-
pected, being able to maintain a sense of control with their wishes
given preference, having access to information and excellent care
and having access to spiritual and emotional support as required (
Steinhauser 2000; Steinhauser 2001). Quality end-of-life care may
vary from person to person and may be difficult to define and ac-
curately measure. However, such care should at least consider the
following domains: quality of life, physical symptoms, emotional
and cognitive symptoms, advanced care planning, functional sta-
tus, spirituality, grief and bereavement; satisfaction and quality of
care, and the caregiver well being (Mularski 2007).
Obstacles to quality end-of-life care have also been identified in
the literature and may include failure to recognise treatment fu-
tility, lack of communication among decision makers, no agree-
ment on a course for end-of-life care, and failure to implement a
timely end-of-life care plan (Travis 2002). In recent years, there
has been a variety of initiatives developed worldwide to target such
issues by developing systemic approaches towards end-of-life care.
Some examples of these initiatives are: the National End of Life
Care Programme (Department of Health 2008), Gold Standards
Framework in Care Homes (Badger 2007) and the Liverpool Care
Pathway (LCP) (Ellershaw 1997; Ellershaw 2003).
Description of the intervention
Integrated care pathways are documents which outline the essen-
tial steps of multidisciplinary care in addressing a specific clinical
problem. They can be used to introduce clinical guidelines and
systematic audits of clinical practice (Hockley 2005). The LCP is
an example of an integrated care pathway specifically for the dying
phase of palliation.
Historically, general hospital care for dying patients tended to be
poor and it was thought that much could be learned from the way
patients were cared for in the hospice movement (Mills 1994).
The LCP was an example of strategies developed by the Royal
Liverpool University Trust and the Marie Curie Centre in Liver-
pool (Ellershaw 1997; Ellershaw 2003) based on the care received
by those in the hospice setting. Other objectives of the pathway
were to promote cost-effective health care by appropriate prescrib-
ing, and avoiding crisis interventions and inappropriate hospital
admissions. The document is patient-centred and focuses on the
holistic needs of people who are dying. It incorporates the phys-
ical, psychological, social spiritual and religious aspects of care (
Ellershaw 2007). The LCP defines 19 goals considered essential
in the management of dying patients and for the care of their rel-
atives/carers after death (Ellershaw 1997; Ellershaw 2003). These
goals were established with the issues identified from surveys, fo-
cus groups, expert opinion and best practice consensus.
More recently, several other groups have developed care pathways
for the dying based on the concept of Ellershaw and colleagues
(Bookbinder 2005; Fowell 2002; Pooler 2003). Whilst the pro-
fessional consensus is that end-of-life care pathways promote best
possible patient outcomes, there is no systematic review substan-
tiating this claim.
How the intervention might work
In many clinical areas, integrated care pathways are utilised as
structured multidisciplinary care plans which detail essential steps
in caring for patients with specific clinical problems (Campbell
1998).Care pathways for the dyinghave beendeveloped as amodel
to improve the end-of-life care of all patients. They ensure that the
most appropriatemanagement occurs at themost appropriate time
and that it is provided by themost appropriate health professional.
Why it is important to do this review
Systematic reviews report that clinical pathways enhance efficiency
of care without adverse effects on outcomes amongst patients who
undergo gastrointestinal surgery (Lemmens 2008) and show a sig-
nificant length of stay reduction in patients who undergo inva-
sive procedures (Rotter 2008). In contrast, the findings from a
Cochrane systematic review reported that there was no significant
benefit in functional outcome, and patient satisfaction and that
quality of life might actually be made worse for patients following
stroke care pathways (Kawn 2004). Therefore, clinical pathways
seem to be beneficial for managing certain clinical problems, but
not all.
Clinical pathways for end-of-life care management are used widely
around the world and have been set as the main part of the End-
of-Life Care Strategy by the Department of Health in the UK (
Department of Health 2008; Veerbeek 2006) as well as being the
Gold Standard Framework (GSF) by the National Health Service
(NHS 2005). There is a significant need for clinicians to be in-
2End-of-life care pathways for improving outcomes in caring for the dying (Protocol)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
formed about the utilisation of end-of-life care pathways with level
I evidence.
O B J E C T I V E S
We aim to assess the effects of end-of-life care pathways, compared
with usual care or with care guided by another end-of-life care
pathway across all healthcare settings (hospitals, residential aged
care facilities, community). In particular, we aim to assess the
effects on symptom severity and quality of life of people who are
dying and/or those related to the care such as families, caregivers
and health professionals.
M E T H O D S
Criteria for considering studies for this review
Types of studies
The review will include clinical trials in which the effect of the
end-of-life care pathway can be compared with a control group
which receives usual care. We will include randomised controlled
trials (RCTs), cluster RCTs and quasi-RCTs. If limited RCTs and
quasi-RCTs are available, we may consider including controlled
before-and-after studies. We will assess the impact this has on
the strength of our recommendations. However, we will not in-
clude any non-controlled studies. The analysis for randomised
and non-randomised studies will be undertaken separately because
non-randomised comparisons may overestimate treatment effects
(Chalmers 1983; Sacks 1982), and the size and direction of the
bias can be unpredictable (Deeks 2003).
Types of participants
Participants in the included studies will be patients and families
who receive care guided by an end-of-life care pathway. Partici-
pants may have different diseases such as cancer or organ failure.
However, participants who receive interventions must be receiving
care guided by an end-of-life care pathway for their last days and
hours of life. There will be no restriction on the age of the partic-
ipant, diagnosis or setting (hospital, home, or nursing home).
Types of interventions
The comparisons will be:
• intervention (receiving care which is guided by an end-
of-life care pathway) versus usual care.
• interventionA (pathwayA) versus interventionB (path-
way B).
An end-of-life care pathway may be part of a larger intervention,
these studies will only be included if the effect of the pathway can
be isolated.
Types of outcome measures
Primary outcomes
• Physical symptom severity (as measured by any instru-
ment used by the author such as Edmonton Symptom
Assessment Scale (Bruera 1991), Memorial Symptom
Assessment Scale (Portenoy 1994).
• Psychological symptom severity (as measured by any
instrument used by the author. For example, Hospital
Anxiety and Depression Scale (Zigmond 1983).
• Quality of life (as measured by any instrument used by
the author such as theMcGill Quality of Life Question-
naire (Cohen 1995)).
Secondary outcomes
• Advanced care planning (as measured by whether it has
happened or not).
• Communication between the healthcare team and fam-
ilies (as measured by whether a recorded family meeting
has happened or not).
• Caregivers well being.
• Grief and bereavement.
• Patient/staff/caregivers’ satisfaction.
• Staff confidence.
• Cost of intervention.
• Cost of care.
• Medication/treatment use.
We will include any tools used by the authors of the included stud-
ies. The validity and reliability of the tools used will be discussed
in the appraisal of the studies.
Search methods for identification of studies
Electronic searches
The Pain, Palliative and Supportive Care Review group will search
their Specialised Register.
We will search:
• the Cochrane Central Register of Controlled Trials
(CENTRAL) on the The Cochrane Library,
• MEDLINE (1950 to present),
• EMBASE (1980 to present),
• PsycINFO (1980 to present),
• CINAHL (1982 to present),
• Web of Science.
The search strategy will be developed to comprise searches both
for keywords andmedical subject headings under existing database
organizational schemes. The strategy for MEDLINE (Ovid SP) is
presented in Appendix 1.
Therewill be no restrictionby language. Foreign language abstracts
will be initially translated for the application of the inclusion and
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exclusion criteria, and where necessary the methods, results and
discussion sections will be translated for inclusion in the review.
Searching other resources
We will search the reference lists of any relevant reviews or other
studies, scanning paper issues of journals relevant to interventions
of end-of-life care pathway and scanning abstracts from relevant
conference proceedings. We will also contact experts in the field
and authors of included studies for advice as to other relevant
studies.
We will search Google for the World Wide Web, Caresearch (
www.caresearch.com.au), the ProQuest Dissertations and Theses
database for grey literature and conference abstracts.Wewill search
databases in TrialsCentral ( www.trialscentral.org), the WHO
Clinical Trial Search Portal ( www.who.int/ trealsearch) and Cur-
rentControlledTrials ( www.controlled- trials.com) to identify on-
going or recently completed studies. If applicable, we will present
relevant ongoing studies in the ’Characteristics of ongoing studies’
table.
Data collection and analysis
Selection of studies
Two review authors will pre-screen all search results (titles and ab-
stracts) for possible inclusion, and those selected by either or both
authors will be subject to full-text assessment. Two review authors
will independently assess the selected articles for inclusion. Any
discrepancies will be resolved by consensus, overseen by a third
review author acting as arbiter, with approval by one review author
and the arbiter being sufficient. We will list those studies excluded
after full-text assessment in the ’Characteristics of Excluded Stud-
ies’ table, giving reasons for exclusion.
Data extraction and management
We will develop a data extraction form based on the Cochrane
Pain, Palliative and Supportive Care ReviewGroup’s template, and
pilot and amend it as necessary.We will extract the following main
sets of data from each included study:
• lead author; date;
• study participant inclusion criteria;
• participants (participant diagnoses/condition(s) andde-
mographics: race/ethnicity, gender, religion/culture, so-
cioeconomic status, age);
• study design and timetable; randomisation; allocation
concealment;
• interventions (end-of-life care pathway type);
• intervention setting (hospital, home, residential aged
care facilities);
• numbers of participants in each trial arm, withdrawals
and dropouts;
• outcome measures; time(s) at which outcomes were as-
sessed.
At least two review authors will independently extract data to
the data extraction form. Any discrepancies will be referred to a
third review author and any errors or inconsistencies resolved by
discussion.The first review authorwill enter the data intoRevMan,
with another review author checking the accuracy of the data entry.
Assessment of risk of bias in included studies
We will assess and report on the risk of bias of included studies
in accordance with the guidelines in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2008), which rec-
ommends the explicit reporting of the following individual do-
mains:
• sequence generation;
• allocation concealment;
• blinding of participants, personnel and outcome asses-
sors (assessed for each main outcome or class of out-
come);
• incomplete outcome data (assessed for each main out-
come or class of outcome);
• selective outcome reporting;
• other sources of bias.
We will also examine and report the following:
• validation and reliability of outcome measures;
• whether the study obtained ethics committee approval
and ensured informed consent for participation;
• use of standardised protocols for information delivery.
We will check for consistency of the delivery of inter-
ventions where possible.
Two review authors will independently assess the risk of bias in
included studies, with any disagreements resolved by discussion
and consensus, and with a third review author acting as arbiter.
We will present our assessment in the risk of bias tables for each
included study. We will contact study authors for additional in-
formation about the study methods as necessary. We will incor-
porate the results of the risk of bias assessment into the review
through narrative description and commentary about each of the
items mentioned.
This will lead to an overall assessment of the risk of bias of the
included studies.
Measures of treatment effect
For individual studies, effect measures for categorical outcomes
will include relative risk (RR) with its 95% confidence intervals
(CI). For statistically significant effects, number needed to treat
to benefit (NNT) will be calculated. If possible for continuous
outcomes, the effect measure will be mean difference (MD) or, if
the scale of measurement differs across trials, standardized mean
difference (SMD), each with its 95% CI. For meta-analyses (see
below), for categorical outcomes, typical estimates of RR with
their 95% CI will be calculated; and for continuous outcomes,
the weighted mean difference (WMD) or a summary estimate for
SMD, each with its 95% CI, will be calculated.
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Data will be analysed using the Cochrane Collaboration’s Review
Manager 5 software.
Unit of analysis issues
We do not anticipate any unit of analysis issues arising. Cross over
trials are not expected for this type of intervention due to the
end-of-life care pathway nature. The pathway focuses on terminal
care. If cluster randomised trials are identified, we will attempt
to conduct analysis at the same level as the allocation, using a
summary measurement from each cluster.
Dealing with missing data
If some outcome data remain missing despite our attempts to
obtain complete outcome data from authors, we will perform an
available-case analysis, based on the numbers of patients for whom
outcome data are known. If standard deviations are missing, we
will impute them from other studies, or where possible, compute
them from standard errors using the formula SD = SE x
√
N,
where these are available (Higgins 2008). We will also report on
levels of drop outs in the intervention and comparison groups as an
indicator of ’acceptability’ of the intervention, and the likelihood
of bias.
Assessment of heterogeneity
Heterogeneity will be tested using the Chi² statistic and any het-
erogeneity will be further quantified with the I² statistic (which
describes the percentage of the variability in effect estimates that is
due to heterogeneity rather than sampling error). A value greater
than 50%will be considered to represent substantial heterogeneity
(Higgins 2008).
Assessment of reporting biases
Reporting bias will be assessed using guidelines in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins
2008). As the review authors do not expect to find a large number
of studies it is unlikely that publication or inclusion bias will be as-
sessed. However, if enough studies are available to do ameaningful
assessment of publication bias, a funnel plot will be constructed.
Data synthesis
If the studies are sufficiently similar in terms of population, inclu-
sion criteria, interventions and/or outcomes (including the time(s)
at which these are assessed), we will consider pooling the data sta-
tistically using meta-analysis. We will report the results of the in-
dividual trials separately where the outcome data is unsuitable for
meta analysis. We will use fixed-effect models when populations
measures are similar and random-effects models where population
parameters vary from study to study.
Subgroup analysis and investigation of heterogeneity
Subgroup analyses will be conducted if sufficient data can sup-
port the analyses. Subgroups may include disease type and settings
where care was received.
Sensitivity analysis
If there are other sources of heterogeneity, we will explore further
by using sensitivity analysis to determine the effects of the end-
of-life care pathways, overall methodological quality and use of
ITT analysis. Studies with high attrition rates (over 50%) will be
removed from the meta-analysis to determine whether the results
would be significantly different without them.
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
Database: OvidMEDLINE(R)
1 Palliative Care/ or palliat$.mp.
2 end-of-life.mp.
3 terminally ill.mp. or Terminally Ill/
4 dying.mp.
5 hospice.mp. or Hospices/
6 end-stage.mp.
7 or/1-6
8 Critical Pathways/
9 ((clinical or critical or care) adj path$).mp.
10 (care adj (map$ or plan$)).mp.
11 exp Guidelines/
12 Health Planning Guidelines/
13 Guideline Adherence/
14 (compliance adj (protocol? or policy or guideline?)).mp.
15 (guideline? adj2 (introduc$ or issu$ or impact or effect? or disseminat$ or distribut$ or implement$)).mp.
16 nursing protocol?.mp.
17 professional standard$.mp.
18 (practice guidelin$ or practice protocol$ or clinical practice guidelin$).mp.
19 or/9-18
20 Guideline.pt.
21 randomized controlled trial.pt.
22 controlled clinical trial.pt.
23 Intervention Studies/
24 experiment$.mp.
25 (time adj series).mp.
26 (pre test or pretest or post test or posttest).mp.
27 Random Allocation/
28 impact.mp.
29 intervention?.mp.
30 Evaluation Studies/
31 Comparative Study.pt.
32 Human/
33 7 and 19 and 32
H I S T O R Y
Protocol first published: Issue 4, 2009
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